Humanigen Inc (fka HGENQ)

[cowtown jay]

Humanigen is not an SEC-reporting company, and management has the majority voting rights. They could have merged without a shareholder vote, which is what I think they did.

But you're right. Management COULD do what is best for them, and they owe shareholders nothing. That's not how they treated the Kalobios shareholders, and that will not be how they treat us.

Long ago, I thought that we were worth an $8B market cap. But our market opportunity has grown substantially. I'm really looking forward to seeing lenz prescribed earlier in the disease progression, even in an out-patient setting, if they can reformulate lenz for a cost-effective administration. But if that effort hasn't yet been advanced, Sanofi, with 70+ products in their development pipeline, may represent overwhelming demand for all of the lenz they can manufacture.

In terms of the lenz patents, what will they be worth once the legitimate LIVE-AIR trial results, with the PREACH-M and RATinG trial results, and the IND data is reported from the Novavax vaccine enhancements, as well as the Mayo Clinic, Gracell, and Arrivent CAR-T enhancements?